Is CLL the Second Cancer? A Single Center Retrospective Analysis of Secondary Malignancies (SM) in Patients with Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Akhtar, Othman Salim [1 ]
Singh, Anil [2 ]
Groman, Adrienne [2 ]
Hernandez-Ilizaliturri, Francisco J. [2 ]
机构：
[1] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Med, Buffalo, NY USA
[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
CLL; secondary cancers; prostate cancer; bladder cancer; renal cell carcinoma;
D O I：
10.1016/j.clml.2018.07.087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-303
引用
收藏
页码：S219 / S219
页数：1
相关论文
共 50 条
  • [31] Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
    C-M Wendtner
    M Ritgen
    C D Schweighofer
    G Fingerle-Rowson
    H Campe
    G Jäger
    B Eichhorst
    R Busch
    H Diem
    A Engert
    S Stilgenbauer
    H Döhner
    M Kneba
    B Emmerich
    M Hallek
    Leukemia, 2004, 18 : 1093 - 1101
  • [32] Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysis
    Cao, Yanglin
    Chen, Yan
    Tao, Tingting
    Gong, Yanlei
    Xu, Chao
    Cen, Jiannong
    Shen, Hongjie
    Pan, Jinlan
    Chen, Suning
    Yao, Li
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (06) : 908 - 916
  • [33] The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia
    Vojdeman, Fie Juhl
    van't Veer, Mars B.
    Tjonnfjord, Geir E.
    Itala-Remes, Maija
    Kimby, Eva
    Polliack, Aaron
    Wu, Ka L.
    Doorduijn, Jeanette K.
    Alemayehu, Wendimagegn G.
    Wittebol, Shulamiet
    Kozak, Tomas
    Walewski, Jan
    Abrahamse-Testroote, Martine C. J.
    van Oers, Marinus H. J.
    Geisler, Christian Hartmann
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 594 - 600
  • [34] Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
    Rogers, Kerry A.
    Thompson, Philip A.
    Allan, John N.
    Coleman, Morton
    Sharman, Jeff P.
    Cheson, Bruce D.
    Izumi, Raquel
    Frigault, Melanie M.
    Quah, Cheng
    Raman, Rakesh K.
    Wang, Min Hui
    Kipps, Thomas J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S282 - S283
  • [35] Cardiovascular Adverse Events (CVAE) Associated With Second Generation Bruton Tyrosine Kinase (BTK) Inhibitor (BTKi) Therapy in Patients With Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Meta-Analysis
    Proskuriakova, Ekaterina
    Shrestha, Dhan
    Jasaraj, Ranjit
    Mercado, Gustavo Espinoza
    Wortstman, Josh
    Kovalenko, Iulia
    Khosla, Pam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S327 - S328
  • [36] Infectious complications in chronic lymphocytic leukemia- a retrospective analysis: single institution experience
    Demitrovicova, L.
    Mikuskova, E.
    Oravcova, I.
    Cingelova, S.
    Drgona, L.
    Mladosievicova, B.
    NEOPLASMA, 2017, 64 (03) : 474 - 481
  • [37] Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
    Darko Antic
    Natasa Milic
    Thomas Chatzikonstantinou
    Lydia Scarfò
    Vladimir Otasevic
    Nina Rajovic
    David Allsup
    Alejandro Alonso Cabrero
    Martin Andres
    Monica Baile Gonzales
    Antonella Capasso
    Rosa Collado
    Raul Cordoba
    Carolina Cuéllar-García
    Juan Gonzalo Correa
    Lorenzo De Paoli
    Maria Rosaria De Paolis
    Giovanni Del Poeta
    Maria Dimou
    Michael Doubek
    Maria Efstathopoulou
    Shaimaa El-Ashwah
    Alicia Enrico
    Blanca Espinet
    Lucia Farina
    Angela Ferrari
    Myriam Foglietta
    Alberto Lopez-Garcia
    José A. García-Marco
    Rocío García-Serra
    Massimo Gentile
    Eva Gimeno
    Maria Gomes da Silva
    Odit Gutwein
    Yervand K. Hakobyan
    Yair Herishanu
    José Ángel Hernández-Rivas
    Tobias Herold
    Gilad Itchaki
    Ozren Jaksic
    Ann Janssens
    Olga B. Kalashnikova
    Elżbieta Kalicińska
    Arnon P. Kater
    Sabina Kersting
    Maya Koren-Michowitz
    Jorge Labrador
    Deepesh Lad
    Luca Laurenti
    Alberto Fresa
    Journal of Hematology & Oncology, 15
  • [38] Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile
    Mauro, Francesca R.
    Molica, Stefano
    Laurenti, Luca
    Cortelezzi, Agostino
    Carella, Angelo M.
    Zaja, Francesco
    Chiarenza, Annalisa
    Angrilli, Francesco
    Nobile, Francesco
    Marasca, Roberto
    Musolino, Caterina
    Brugiatelli, Maura
    Piciocchi, Alfonso
    Vignetti, Marco
    Fazi, Paola
    Gentile, Giuseppe
    De Propris, Maria S.
    Della Starza, Irene
    Marinelli, Marilisa
    Chiaretti, Sabina
    Del Giudice, Ilaria
    Nanni, Mauro
    Albano, Francesco
    Cuneo, Antonio
    Guarini, Anna
    Foa, Robin
    LEUKEMIA RESEARCH, 2014, 38 (02) : 198 - 203
  • [39] Patterns of Treatment and Prognostic Testing Among Black Patients With Chronic Lymphocytic Leukemia (CLL): Results From informCLL, a Prospective, Observational Registry
    Barrientos, Jacqueline
    Mato, Anthony
    Sharman, Jeff
    Brander, Danielle
    Gutierrez, Meghan
    Wu, Linda
    Panjabi, Sumeet
    Young, Alex
    Upasani, Sandhya
    Naganuma, Maoko
    Ghosh, Nilanjan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S279 - S279
  • [40] Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
    Antic, Darko
    Milic, Natasa
    Chatzikonstantinou, Thomas
    Scarfo, Lydia
    Otasevic, Vladimir
    Rajovic, Nina
    Allsup, David
    Cabrero, Alejandro Alonso
    Andres, Martin
    Gonzales, Monica Baile
    Capasso, Antonella
    Collado, Rosa
    Cordoba, Raul
    Cuellar-Garcia, Carolina
    Correa, Juan Gonzalo
    De Paoli, Lorenzo
    De Paolis, Maria Rosaria
    Del Poeta, Giovanni
    Dimou, Maria
    Doubek, Michael
    Efstathopoulou, Maria
    El-Ashwah, Shaimaa
    Enrico, Alicia
    Espinet, Blanca
    Farina, Lucia
    Ferrari, Angela
    Foglietta, Myriam
    Lopez-Garcia, Alberto
    Garcia-Marco, Jose A.
    Garcia-Serra, Rocio
    Gentile, Massimo
    Gimeno, Eva
    da Silva, Maria Gomes
    Gutwein, Odit
    Hakobyan, Yervand K.
    Herishanu, Yair
    Hernandez-Rivas, Jose Angel
    Herold, Tobias
    Itchaki, Gilad
    Jaksic, Ozren
    Janssens, Ann
    Kalashnikova, Olga B.
    Kalicinska, Elzbieta
    Kater, Arnon P.
    Kersting, Sabina
    Koren-Michowitz, Maya
    Labrador, Jorge
    Lad, Deepesh
    Laurenti, Luca
    Fresa, Alberto
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
12345